SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-18-164065
Filing Date
2018-05-15
Accepted
2018-05-15 16:02:04
Documents
2
Group Members
AMIN NATHOOANSON ADVISORS INC.ANSON MANAGEMENT GP LLCBRUCE R. WINSONMOEZ KASSAM

Document Format Files

Seq Description Document Type Size
1 SC 13G d586369dsc13g.htm SC 13G 117890
2 EX-99.1 d586369dex991.htm EX-99.1 8158
  Complete submission text file 0001193125-18-164065.txt   127792
Mailing Address 5950 BERKSHIRE LANE SUITE 210 DALLAS TX 75225
Business Address 5950 BERKSHIRE LANE SUITE 210 DALLAS TX 75225 214.866.0202
Anson Funds Management LP (Filed by) CIK: 0001491072 (see all company filings)

IRS No.: 300134498 | State of Incorp.: TX | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 332 EAST SCOTT STREET PORT HUENEME CA 93041
Business Address 332 EAST SCOTT STREET PORT HUENEME CA 93041 (805) 488-2800
Stellar Biotechnologies, Inc. (Subject) CIK: 0001540159 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1029
Type: SC 13G | Act: 34 | File No.: 005-87615 | Film No.: 18836204
SIC: 2834 Pharmaceutical Preparations